Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Shanghai Stock Exchange:603392.SS
Sector
Location
Market Cap
USD 9.63 B
Share Price
USD 7.61
Avg Daily Volume
5,129,039
Change (1 day)
0.24%
Change (1 year)
-21.17%
Change (YTD)
-21.15%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 48.63 M
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow is USD 48.63 M for the year ending December 31, 2024, a -77.55% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 216.60 M, a -63.83% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 598.85 M, a 126.23% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 264.70 M, a 269.03% change year over year.
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 71.73 M, a 83.18% change year over year.
StockViz
Competitors
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Labcorp Holdings Inc.
USD 270.38
LH
-0.87
-0.32%
Sino Biopharmaceutical Limited
USD 1.00
1177.HK
+0.03
2.72%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.19
300832.SZ
+0.21
2.67%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.34
0874.HK
+0.02
0.70%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.94
600079.SS
-0.00
-0.04%
AddLife AB (publ)
USD 17.22
ALIF-B.ST
+0.03
0.20%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
+0.07
1.65%
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Labcorp Holdings Inc.
USD 270.38
LH
-0.87
-0.32%
Sino Biopharmaceutical Limited
USD 1.00
1177.HK
+0.03
2.72%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.19
300832.SZ
+0.21
2.67%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.34
0874.HK
+0.02
0.70%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.94
600079.SS
-0.00
-0.04%
AddLife AB (publ)
USD 17.22
ALIF-B.ST
+0.03
0.20%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
+0.07
1.65%
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%